
Syncromune®
Syncromune is a clinical-stage biopharmaceutical company developing SYNC-T, a first-in-class cancer immunotherapy platform for metastatic solid tumors. The company has raised $155M in Series A funding and employs 58 people.
The growth story

Syncromune® grew from 9 to 58 employees between 2022 and 2026, raising $155M along the way, most recently a Series A in December 2024.
About
Syncromune's SYNC-T platform is an in situ personalized cancer therapy designed to synchronize tumor antigens, immune cells, and a multi-target biologic drug at the tumor site. It uses a proprietary device delivery system optimized for combination therapy. The therapy targets incurable metastatic solid tumors, addressing unmet needs in cancer treatment.
The company, founded in 2020, has raised $155M in Series A funding as of December 2024. With 58 employees, Syncromune is advancing its LEGION-100 trial for metastatic prostate cancer, which is currently enrolling patients.
Founders and leadership
Syncromune's leadership includes a strong operations team, with five employees in that function. The company is headquartered in Fort Lauderdale, Florida, and has a median employee tenure of two years.












The Syncromune® org chart
Eamonn Hobbs (Founder, President & CEO) leads 33 mapped leaders with 7 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew

Headcount by function: Business Development 9 (+13% YoY), Research 8 (+60% YoY), Healthcare Services 6 (+100% YoY), Legal 5 (+25% YoY), Information Technology 4 (+300% YoY), Engineering 4 (0% YoY).
Talent flow
Syncromune's team includes professionals from ImmunSYS, Delcath, and NewLink Genetics, with several also having experience at AngioDynamics and E-Z-EM. Alumni have moved on to roles at Dugri, Kazia Therapeutics, and BleuConsult.

Most common previous employers of Syncromune® staff: ImmunSYS (7), Delcath (4), NewLink Genetics (4), AngioDynamics (3), E-Z-EM (3), The National Institutes of Health (3). Former Syncromune® employees most often moved to Dugri (1), Founder & Systems Strategist (1), 1130.Works (1), SoLá Pelvic Therapy (1), Kazia Therapeutics (1), BleuConsult (1).
Web traffic

Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of

Most common skills at Syncromune®: Leadership (22), Project Management (21), Biotechnology (19), Medical Devices (19), Pharmaceutics (17), Microsoft Office (17), Management (16), Oncology (16).
Where the team actually sits

Syncromune® people are concentrated in Florida, United States (8), New York, United States (5), Greater Philadelphia (4), Miami-Fort Lauderdale Area (3).
Search footprint
Syncromune® attracts about 44 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 11 ranking keywords and lost 6 in the last period.
Frequently asked
Syncromune® has 58 employees as of September 2026.
Syncromune® has raised $155M in total, most recently a Series A round in December 2024.
Syncromune® was founded in 2020 by Eamonn Hobbs.
Eamonn Hobbs (Founder, President & CEO) sits at the top of Syncromune®'s reporting structure, with 7 direct reports.
The most common previous employers of current Syncromune® staff are ImmunSYS (7 people), Delcath (4 people), NewLink Genetics (4 people).
Former Syncromune® employees most often move to Dugri (1), Founder & Systems Strategist (1), 1130.Works (1).
Syncromune® attracts about 44 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Syncromune® staff are Leadership, Project Management, Biotechnology, Medical Devices, Pharmaceutics.
Syncromune® staff are concentrated in Florida, United States (8), New York, United States (5), Greater Philadelphia (4).
Syncromune® has about 9 people in Business Development, up 13% over the past year, as of September 2026.
Syncromune® has about 8 people in Research, up 60% over the past year, as of September 2026.
Computed from 45 current and 9 former Syncromune® profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.